Guillain-Barre Syndrome

Inspiration:
Follow-up Rounds Presentation
12/18/2015
Dr. Eliot Lee, PGY-3

THE CASE

CC: Shortness of breath
HPI:
  • 42 yo M with no PMH BIBEMS for SOB and generalized weakness
  • Nausea, vomiting, diarrhea x 3 days
  • Became acutely dyspneic on day of presentation
  • Unable to ambulate
  • Slurred speech 
PMH/PSH: Denies
Medications: Denies

Allergies: NKMA

Physical Exam
Vitals: BP 205/95, HR 72, RR 16, T 98.0, O2 90% on 15L NRB
General: Intubated/sedated, opens to verbal stimulation, moves eyes toward voices
HEENT: R pupil 5mm, L pupil 2mm, both reactive to light, no corneal reflex
CV: RRR, S1, S2, no murmurs
Pulm: Equal, diminished, bilateral rales at bases
Abdomen: Soft, NT, ND

Neuro: No spontaneous movement or response to noxious stim in any extremity, DTRs 0 bilaterally

 

Studies:
CBC: 8.9>14.7/46.5<192
Chem: 139/4.4  106/28.2  14/1.0  < 117
TSH: 0.625, Free T4 1.46
Vit B12: 363
Folic Acid: 17.3
CK: 502, Trop: 0.006
Lactate: 2.06
VBG: 7.288/60.3/118.5/97.8/28.2 on Vent 100 FiO2

LP: Normal

CXR: LLL infiltrate

NCHCT: No acute pathology

Hospital Course:
  • Admitted to MICU
  • EMG: Severe demyelinating polyneuropathy 
  • Repeat LP with ↑, nl WBC
  • IVIG started
  • Became bradycardic to 30s → Transvenous pacer placed

BACKGROUND
  • Acute polyneuropathy 2/2 immune-mediated peripheral nerve myelin sheath destruction
  • Cause unknown
    • Suspected: viral/febrile illness (C. jejuni), vaccination
  • S/sx worsen over 2-4w; recovery = weeks to years
  • 70% of pts develop dysautonomia 
PRESENTATION
  • Ascending weakness/paralysis
    • May affect diaphragm
      • 1/3 of patients require ETT
  • Loss of DTRs
  • Diagnostic criteria:
    • Required
      • Progressive weakness of >1 limb
      • Areflexia
    • Suggestive
      • Progression over days
      • Recovery beginning 2-4 wk after cessation of progression
      • Relative symmetry of symptoms
      • Mild sensory s/sx
      • CN involvement (Bell’s palsy, dysphagia, dysarthria, ophthalmoplegia)
      • Autonomic dysfunction (tachycardia, bradycardia, dysrhythmias, wide variations in BP, postural HoTN, urinary retention, constipation, facial flushing, anhydrosis, hypersalivation)
      • Absence of fever at onset
      • Cytoalbuminologic dissociation of CSF (↑ protein, nl WBC)
        • In 50-66% of pts at onset
        • Protein >45 mg/dL
        • WBCs <10 cells/mm3
        • Consider HIV if WBC >10 cells/mm3
  • Miller-Fisher variant
    • A/w C. jejuni infxn
    • Preceded by diarrhea (rather than viral prodrome)
    • Signs: Ophthalmoplegia, ataxia, decreased/absent DTRs
    • Weakness less severe than GBS
    • Antibody testing for C. jejuni for Dx
MANAGEMENT
  • Assess respiratory function
    • Vital capacity best parameter
      • Trend in ED: Have pt count from 1 to 25 in single breath
    • Indications for intubation
      • VC <15 mL/kg
      • PaO2 <70 mmHg on RA
      • Bulbar dysfunction (difficulty breathing, swallowing, or speech)
  • Indications for ICU admission
    • Autonomic dysfunction
    • Bulbar dysfunction
    • Inability to ambulate
    • Treatment with plasmapheresis
  • Who to treat:
    • IVIG
      • Nonambulatory pts within 2 weeks of symptom onset
  • IVIG vs plasmapharesis
    • IVIG a/w thromboembolism and asceptic meningitis
    • Plasmapheresis a/w greater hemodynamic instability, lower rate of relapse
    • Combined IVIG and plasmapharesis no better than single therapy (IVIG or plasmapharesis)
    • IVIG preferred due to convenience and availability
  • Indications for pacemaker placement
    • Severe bradycardia 
REFERENCES

Tintinalli, Judith E., and J. Stephan. Stapczynski. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York: McGraw-Hill, 2011.

Vriesendorp, Francine. “Clinical features and diagnosis of Guillain-Barré syndrome in adults.” Up To Date. http://www.uptodate.com, 17 Nov. 2015. Web. 15 Jan. 2015. http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-guillain-barre-syndrome-in-adults

Vriesendorp, Francine. “Treatment and prognosis of Guillain-Barré syndrome in adults.” Up To Date. http://www.uptodate.com, 3 Jun. 2015. Web. 15 Jan. 2015. http://www.uptodate.com/contents/treatment-and-prognosis-of-guillain-barre-syndrome-in-adults

Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012; 366:2294.

Additional FOAM Resources:

Uterine Rupture

Article inspired by:
Anna Meyendorff, MD
Follow-up Rounds 12/11/15

THE CASE
CC: Abdominal pain

Vitals: T 97.4, BP 70/44, HR 122, RR 22, O2 100% on RA

HPI:
  • 27 yo F 17 weeks gestation by LMP
  • Acute onset pain 1 hour
  • Diffuse radiating to back, sharp, 10/10 intensity
  • Emesis x 2
  • No prenatal care
PMH/PSH: G6P3, Osteogenesis Imperfecta; cesarean section x 2
Medications: Denies
Allergies: NKMA

Social: Denies toxic habits

Physical Examination:
Vitals: as above
General: AAOx3, moderate distress, tachypneic, blue sclerae
CVS: Tachycardic, regular rate, S1, S2
Pulm: CTAB
Abd: Soft, diffusely tender, gravid abdomen

Pelvic: Closed OS, no blood in vault

Studies:
CBC: WBC 20.9, Hgb 6.1, Hct 19.1, Plt 243
BMP: Na 139, K 3.4, Cl 109, BUN 13, Cr 0.51 Glucose 366, AG 20
Lactate 5.7
bHCG 2337

Rh+

CT A/P: Uterine rupture with hemoperitoneum

BACKGROUND
  • Prevalence
    • No prior c-section = 0.01%
    • Prior c-section = 0.2-0.8%
  • Risk factors
    • Prior c-section (major)
    • Malpresentation
    • Labor dystocia
    • Hypertension
    • Bicornuate uterus
    • Grand multiparity
    • Connective tissue disorder
    • Placenta percreta
    • Prior myomectomy
    • Misoprostol use (oxytocin likely safe)
  • Typically occurs during labor
In whom should I suspect rupture?
  • Those with above risk factors plus
    • Acute onset/worsening and severe abdominal pain
    • Vaginal bleeding (may be minimal)
    • Palpable uterine defect on exam
    • Hemodynamic instability
What will I see on transabdominal US?
  • Disruption of myometrium
  • Free peritoneal fluid (FAST+)
  • Anhydramnios/empty uterus
  • Herniated amniotic sac
  • Fetal anatomy outside of uterus
  • Absence of FHR
uterine rupture
uterine rupture 4
And if US is non-diagnostic?
  • CT A/P if reasonably stable
  • MRI in the rock-solid stable patient
What else should we consider in the hypotense, gravid patient with abdominal pain?
  • Septic shock
    • Appendicitis
    • Pyelonephritis
    • Cholecystitis/Cholangitis
    • Pneumonia
  • GYN pathology
    • Septic abortion
    • Rupture ectopic
  • Ruptured AAA
  • DKA
What’s the next step once the diagnosis is made?
  • Get OBGYN following ASAP
  • IVF and blood transfusion as indicated
  • Prep patient for emergent c-section or ex-lap
  • Consider GU consult if hematuria
    • Large ruptures may extend into bladder
    • Some uterine rupture repairs require intraop GU consult
REFERENCES

Lang, Christoper. “Uterine dehiscence and rupture after previous cesarean delivery.” Up To Date. http://www.uptodate.com, 15 Oct. 2015. Web. 28 Dec. 2015. http://www.uptodate.com/contents/uterine-dehiscence-and-rupture-after-previous-cesarean-delivery

Meyendorff, Anna. “Uterine Rupture.” 11 Dec. 2015. Follow-up Rounds, Emergency Medicine Conference.

Tintinalli, Judith E., and J. Stephan. Stapczynski. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York: McGraw-Hill, 2011.

Thyroid Storm

Follow-Up Rounds (10/2/15)
Article Inspired by: Adelle Iusim, PGY-3


THE CASE:

CC: Body aches, Fever, Left-sided abdominal pain x 3 weeks

Triage Vitals- BP-125/78, HR: 99, RR: 18, SpO2-93%, Temperature: 100.8F

HPI: 25 y/o F presents with abdominal pain (left sided, generalized cramping), subjective fever/chills, and myalgias x 3 days. She reports persistent nausea and vomiting with PO intake. She also endorses urinary frequency and a foul smelling urine.

PMHx: Hyperthyroidism, Seizures(?), Latent tuberculosis
PSHx: none
Meds: cannot recall
Allergies: NKDA

Pertinent positives on physical exam:
HEENT: Dry mucous membranes
Cardiovascular: Tachycardic
Abdomen: BS+ x4, Soft, NT/ND
Back: B/l CVA tenderness

EKG: Sinus tachycardia @130bpm

Differential Diagnosis:

  • Infectious:
    • Influenza
    • Viral Syndrome
    • Strep
    • Pneumonia
    • Encephalitis
    • Meningitis
    • Intraabdominal pathology
    • UTI
    • Pyelonephritis
  • Cardiovascular/Endocrine:
    • Arrythmia
    • Hyperthyroidism
    • Thyroid Strom
    • Toxidrome due to drugs
    • Pheochromocytoma

Labs:
Na: 135, K: 4.7, Cl: 102, HCO3: 20.8, BUN: 15, Cr: 0.4, Glu: 97

Ca: 9.3, Mg: 2.2,T. Prot: 8.3, Albumin: 4.1, T. Bili: 1.2, Alk Phos: 232, AST: 25, ALT: 35; AG: 12.2

WBC: 13.5, Hgb: 13.8, Hct: 41.1, Plt: 231, MCV: 81, Gr: 66.9, Lym: 26.2

UA: Cloudy, glucose negative, bili negative, ketones trace, sp grav: 1.02, large blood; +nitrite; large leuk esterase; WBC: 479; RBC: 191; Bacteria 4+; Epithelial 81; Micro: WBC: many, RBC: 7-10, Bacteria: many

CXR- no acute cardiopulmonary process

TSH: <0.008, Free T4: 11.13

Management:

After further questioning (and eliciting palpitations, weight loss, insomnia on ROS) and further examination (significant for mild exopthalmos and hyperreflexia), she was given Tylenol, 1L NS, Ceftriaxone 1g IV and endocrine was called for likely Grave’s disease.

Endocrine consult: Methimazole 30mg orally; Wait 1 hr, give 5 drops of 0.25mL Potassium Iodide sski q6hr; Atenolol 50mg q8hr (with titration to HR of 80); Check TPO and TSI antibody; Consider steroids if patient deteriorates.

Hospital Course:

Continued on Atenolol, Methimazole. Hydrocortisone 100mg q8hr was started, 0.25mL SSKI potassium iodide q6hr was restarted.

Continued treatment with Ceftriaxone for 2 days, and once cultures came back as pansensitive, switched to Ciprofloxacin for 2 days.

TSI 5.9 (<1.3 is normal), Thyroid peroxidase antibody <10 (<35 is normal)

Discharged after 2 days on Atenolol 50mg TID and Methimazole 30mg daily with endocrine outpatient followup.


 

THE TALK

Thyroid Storm:

  • Rare, life threatening exacerbation of hyperthyroid state with 1 or more organ dysfunction
  • Unclear etiology-
    • Rapid rate of increase in serum thyroid hormone levels
    • Increased responsiveness to catecholamines
    • Enhanced cellular responses to thyroid hormone

WHEN DOES THYROID STORM OCCUR?

  • Systemic insult
    • Infection
    • Trauma
    • Surgery (usually 6-24 hours post)
    • Hyperosmolar coma
  • Endocrinal insult
    • DKA
  • Drug/Hormone-related
    • Withdrawal of thyroid medication
    • Acute iodine load
    • Thyroid gland palpation
    • Ingestion of thyroid hormone
  • Cardiovascular insult
    • MI
    • CVA
    • PE
  • Pregnancy related
    • Parturition
    • Eclampsia

WHAT EFFECTS CAN IT HAVE ON THE BODY?

  • Direct ionotropic and chronotropic effects:
    • Decreased systemic vascular resistance
    • Increased blood volume
    • Increased contractility
    • Increased CO
  • Exaggeration of hyperthyroidism symptoms:
    • Fever (104F-106F)
    • Tachycardia >140 beats/min
    • Altered Mental Status (agitation, anxiety, delirium, psychosis, stupor, coma)
    • Severe nausea, vomiting, diarrhea, abdominal pain, hepatic failure with jaundice
    • Congestive heart failure
    • Cardiac arrhythmia (severe tachycardia or atrial fibrillation in 10-35% cases)
    • Enhanced contractility → elevations in systolic BP and pulse pressure –> dicrotic or water-hammer pulse
    • Death

WHAT SHOULD I LOOK FOR IN MY PHYSICAL EXAM?

  • Goiter
  • Exopthalmous (to think about Grave’s)
  • Lid lag
  • Hand tremor
  • Warm and moist skin

WHAT OTHER DIAGNOSES SHOULD I BE CONSIDERING?

  • Infection/Sepsis
  • Sympathomimetic ingestion (ex: cocaine, amphetamine, ketamine drug use)
  • Heat exhaustion
  • Heat stroke
  • Delirium tremens
  • Malignant hyperthermia
  • Malignant neuroleptic syndrome
  • Hypothalamic stroke
  • Pheochromocytoma
  • Medication withdrawal (ex: cocaine, opioids, etc)
  • Psychosis
  • Organophosphate poisoning

WHAT LAB TESTS SHOULD I ORDER?

  • Chemistry
    • Creatinine may be low
    • Mild hypercalcemia (hemoconcerntration and enhanced bone resorption)
    • Mild hyperglycemia (Catecholamine induced inhibition of insulin release and increased glycogenolysis)
  • CBC
    • Thrombocytopenia
    • Leukocytosis or Leukopenia
  • TFTs (degree of thyroid hormone excess not more profound than uncomplicated thyrotoxicosis)
    • Low TSH
    • High free T4 and or T3
  • LFTs
  • Cortisol level (to rule out concurrent adrenal insufficiency)

IS THERE A CLINICAL TOOL I CAN USE TO DIAGNOSE IT?

Burch and Wartofsky scoring system (sensitive but not very specific)

  • Thermoregulatory Dysfunction
    • Temp 99 to 99.9F = 5 points
    • Temp 100 to 100.9F = 10 points
    • Temp 101 to 101.9F = 15 points
    • Temp 102 to 102.9F = 20 points
    • Temp 103 to 103.9F = 25 points
    • Temp > 104F = 30 points
  • CNS effects
    • Mild (agitation) = 10 points
    • Moderate (delirium, psychosis, extreme lethargy) = 20 points
    • Severe (seizure, coma) = 30 points
  • GI-Hepatic dysfunction
    • Moderate (abdominal pain, nausea, vomiting, diarrhea) = 10 points
    • Severe (unexplained jaundice) = 20 points
  • Cardiovascular dysfunction
    • Tachycardia
      • HR 99-109 = 5 points
      • HR 110-119 = 10 points
      • HR 120-129 = 15 points
      • HR 130-139 = 20 points
      • HR >140 = 25 points
    • Atrial fibrillation = 10 points
  • Heart Failure
    • Mild (pedal edema) = 5 points
    • Moderate (bibasilar rales) = 10 points
    • Severe (pulmonary edema) = 15 points
  • Precipitant history
    • Negative = 0 points
    • Positive = 10 points
  • If score >45: highly suggestive of thyroid storm
  • If score 25-44: impending storm
  • If score <25: thyroid storm unlikely

HOW DO I MANAGE THIS?

  • Supportive care
    • IVF with dextrose (to replenish glycogen stores)
    • MVI/Thiamine (to prevent Wernicke’s when giving dextrose)
    • Tylenol (not NSAIDS or ASA)
      • Aspirin can increase serum free T4 and T3 by interfering with protein binding
    • Bile acid sequestrants (ex: Cholestyramine- to decrease enterohepatic recycling of thyroid hormones)
  • Block peripheral effect of thyroid hormone
    • Beta blocker (to control symptoms/signs induced by increased adrenergic tone- slows HR, increases diastolic filling and decreases tremor)
  • Stop the production of thyroid hormone
    • Thionamide: Methimazole or PTU (slow conversion of T4 to T3 in periphery)
      • PTU favored over Methimazole acutely because of PTU’s effect to decrease T4 to T3 conversion
      • Methimazole has a longer duration of action, is less hepatotoxic, and over weeks of treatment, may result in more rapid normalized of serum T3 than PTU
    • Glucocorticoids (to reduce T4 to T3 conversion, promote vasomotor stability and possible treat associated relative adrenal insufficiency)
    • Iodinated radiocontrast agent (to inhibit peripheral conversion of T4 to T3)- not available in US
  • Inhibit hormone release
    • Iodine solution 1-2 hours after (to decreases release of thyroid hormone from thyroid)
      • Delayed for an hour to prevent iodine from being used as substrate for new hormone synthesis

WHAT IF THEIR SCORE IS 25-44 (IMPENDING STORM)?

  • Beta blocker (ex: propranolol 60 to 80 mg q4-6hr until HR controlled)- can require high doses because of increased drug metabolism as a result of hyperthyroidism
    • Can alternatively use Esmolol (loading dose 250-500mcg/kg, followed by infusion at 50-100mcg/kg per minute)
    • If beta blockers contraindicated, can use CCB (ex: Diltiazem)
  • Propylthiouracil 200mg q4hr OR Methimazole 20mg q4-6hr
  • 1 hour after first dose thionamide taken, Iodine (saturated solution of potassium iodide [SSKI]) 5 drops q6hr OR Lugol’s solution 10 drops q8hr

AND IF THEIR SCORE IS > 45 (LIKELY THYROID STORM)?

In addition to the above,

  • Glucocorticoids (Hydrocortisone 100mg IV q8hr)
  • Cholestyramine 4g QID
  • Treatment of any precipitating factors
  • Some patients require fluids while others require diuresis (ex: CHF)
  • Tylenol instead of ASA

IS SURGERY EVER AN OPTION?

  • Surgery is treatment of choice for patients who cannot take thionamide (ex: due to agranulocytosis or hepatotoxicity or allergy)
  • Still require preoperative treatment with:
    • Beta blockers (propranolol)
    • Glucocorticoids
    • Bile acid sequestrants (cholysteramine 4mg orally QID)
    • Patients with Grave’s disease: Iodide (SSKI) 5 drops q6hr or Lugol’s 10 drops q8hr)
    • If not effective, plasmapheresis (removes cytokines, antibodies and thyroid hormones from plasma)

REFERENCES

Iusim, A. “Follow up Rounds: Thyroid Storm” Jacobi Medical Center. Jacobi/Montefiore Emergency Medicine Conference. Bronx. Oct 2015. Case Presentation

Ross, Douglas S., MD. “Thyroid Storm.” UpToDate, 12 Feb. 2015. Web.

Tintinalli, Judith E., and J. Stephan. Stapczynski. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 7th ed. New York: McGraw-Hill, 2011.

Weingart, Scott. “Podcast 149 – Thyroid Storm.” Podcast 149- Thyroid Storm. Emcrit, 16 May 2015. Web. <http://emcrit.org/podcasts/thyroid-storm/&gt;.

Metformin Associated Lactic Acidosis

Follow-Up Rounds

7/25/2015
Presenter: Dr. Mayuri Patel, PGY-3
Metformin Associated Lactic Acidosis
Synopsis: Great case and discussion on a rare complication of a commonly prescribed medication that touches on some important toxicologic topics.


 

The Case

CC: 66 female presents with abdominal pain, nausea, diarrhea x 3d

HPI

  • Generalized abdominal pain
    • ↓PO intake x 1w
    • a/w N/D
  • Denies f/c/recent travel/recent hospitalization/sick contacts/recent changes in medication/CP/SOB/cough/urinary complaints
  • Reports increase in chronic LBP for which she takes ibuprofen

PMH: DM, HTN, HLD, Chronic LBP
PSH: Hysterectomy
Medications: Statin, metformin, glipizide, HCTZ, ASA, ibuprofen
Allergies: NKMA
Social: Denies EtOH, tobacco, illicit substance use

PHYSICAL EXAM
Vitals: BP 105/70, HR 70, RR 20, O2 sat 95% on RA, FS 110
General: AAOx1 (not baseline), uncomfortable, following commands
HEENT: Dry MM
CVS: RRR, S1, S2, no murmurs
Pull: CTAB
Abd: +BS, soft, NT, ND
Ext: No cyanosis or edema

STUDIES
CBC: 20 > 13.3/34 < 310
BMP: 137/5.7   100/7   90/7.3   < 168; AG 30
LFTs: WNL
Lactate: >20
VBG: pH 6.7, pCO2 20, pO2 75

ED COURSE
Within 30 minutes of evaluation, patient noted to be tachypneic, altered, dropping O2 saturation, and hypotense to SBP 80-90s.

DIAGNOSIS: Metformin-associated lactic acidosis


 

Teaching points

Two types of lactic acidosis 

  • Type A
    • Due to impaired tissue perfusion
    • Commonly in the following
      • Hypovolemia
      • Heart failure
      • Sepsis
  • Type B
    • Due to decreased utilization of lactate
    • May be due to:
      • Alcoholism
      • ↓ Lactate utilization secondary to hepatic dysfunction
      • ↓ NAD+/NADH ratio leads to ↑ conversion of pyruvate to lactate
      •  Metformin
      • DKA (D-lactate production)
      • Liver Disease
      • Malignancy
      • CO poisoning
      • Cyanide poisoning

Metformin-associated Lactic Acidosis

Background
  • Acute and chronic use of metformin can lead to rare complication of Metformin-associate lactic acidosis (MALA)
  • Excreted (unmetabolized) in proximal tubules
  • Lactate accumulation due to:
    • Increased anaerobic glucose metabolism in splanchnic bed
    • Decreased glucosegenesis from lactate
  • Associated with overdose, renal failure, liver disease, and septicemia
  • Acidosis onset several hours after acute ingestion
  • Mortality rate 45%
    • Lactate only predictive of mortality in overdose patients, not in incidental metformin accumulation
      • pH >6.9, lactate >25 portends a poor prognosis
    • Elevated PT associated with increased mortality
Clinical Features
  • Nausea
  • Vomiting
  • Diarrhea
  • Altered mental status
  • Dyspnea
  • Hypotension
  • Tachycardia
  • Tachypnea
Diagnosis
  • FS
  • [ASA]
  • [APAP]
  • EKG
  • bHCG
  • ABG
  • Chem
  • Lactate
Management
  • If intubated, maintain minute ventilation so as to not remove respiratory compensation for acidosis
  • Activated charcoal if peri-ingestion/AMS appropriate
  • Metformin should not cause hypoglycemia and, if present, should lead to work up of cause
  • Sodium Bicarbonate
    • No evidence to support its use in MALA patients
  • Renal Replacement Therapy
    • Metformin can be cleared with hemodialysis and CVVH (continuous venovenous hemofiltration)
      • Former preferred
      • CVVH should be used in unstable patient
    • Reduction in metformin levels following acute ingestion reported to require prolonged HD
    • Consider if:
      • pH <7.1
      • Renal insufficiency
    • Mortality benefits mainly from improving acidosis rather than removing Metformin
References
  1. Goldfrank, Lewis R. Goldfrank’s Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill, 2011
  2. Seidowsky, A., Nseir, S., Houdret, N., & Fourrier, F. Metformin-associated lactic acidosis: a prognostic and therapeutic study. Critical Care Medicine 2009;7:2191–2196.
  3. Dell’Aglio, D. M., Perino, L. J., Kazzi, Z., Abramson, J., Schwartz, M. D., & Morgan, B. W. Acute metformin overdose: examining serum pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Annals of Emergency Medicine 2009;6:818–823.
  4. Kruse, J. A. Metformin-associated lactic acidosis. The Journal of Emergency Medicine 2001;3:267–272.
  5. Barrueto, F., Meggs, W. J., & Barchman, M. J. Clearance of metformin by hemofiltration in overdose. Journal of Clinical Toxicology 2002;2:177–180.
  6. Rifkin, S. I., McFarren, C., Juvvadi, R., & Weinstein, S. S. Prolonged hemodialysis for severe metformin intoxication. Renal Failure 2011;4:459–461.

FOAM RESOURCES

  1. http://lifeinthefastlane.com/ccc/metformin-related-lactic-acidosis/